Europas Finanzierungslücke beginnt eine Stufe vor den Start-ups: bei den Investoren der Venture-Capital-Fonds selbst. Zwischen 2013 und 2023 stammten in der EU rund 30 Prozent des VC-Fundraisings von ...
AI tools can help identify and fix common Excel formula errors by analyzing formulas, finding mistakes, and suggesting improvements. This content highlights ways to use AI assistance for faster ...
A major phase 3 clinical trial was widely expected to confirm the lipoprotein(a) [Lp(a)] hypothesis — that lowering it yields cardiovascular benefit. Harpreet Bhatia, MD When the disappointing results ...
A recent update introduced a new bug affecting pasting in Excel Excel 2016 just got a hotfix, but Microsoft admits issues can persist Temporary workaround is available by selecting 'Paste Special' ...
Microsoft Excel can stop opening for several reasons. You may double-click an Excel file and nothing happens; Excel may crash during startup; or the program may open to a blank screen. Some users also ...
While Windows users are disappointingly familiar with updates causing problems, the same cannot be said of people using Microsoft Office. But with the release of the KB5002914 update for Excel, ...
At around the same time that a humanoid robot broke Usain Bolt’s record for the 100 meters, I was pushing the button to make people like Diarmuid Early irrelevant. Early, the winner of the Microsoft ...
Available for Microsoft 365 Copilot users, the new agents will help you create, edit, and analyze your documents, spreadsheets, and presentations. Microsoft 365 users looking for assistance in Word, ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Emerging venture managers increasingly value smaller family office commitments over large ...
Read about how mathematicians are dealing with the AI takeover of their field in our newest feature here. For the second time ever, someone has solved one of the seven Millennium Prize Problems—math’s ...
The much-anticipated Lp(a)HORIZON trial testing whether the novel drug pelacarsen can improve cardiovascular outcomes by decreasing lipoprotein(a) levels has failed to meet its primary endpoint.
Novartis’ pelacarsen failed to reduce cardiovascular events despite lowering the harmful cholesterol Lp(a). The setback raises uncertainty for rival experimental Lp(a) drugs from Amgen and Eli Lilly.